- Report
- August 2025
- 284 Pages
Global
From €5172EUR$5,850USD£4,465GBP
- Report
- September 2024
- 188 Pages
Global
From €3979EUR$4,500USD£3,435GBP
- Report
- March 2025
- 200 Pages
Global
From €3970EUR$4,490USD£3,427GBP
- Report
- August 2025
- 471 Pages
Global
From €5172EUR$5,850USD£4,465GBP
- Report
- June 2025
- 200 Pages
Global
From €2466EUR$2,789USD£2,129GBP
- Report
- April 2023
- 117 Pages
Global
From €4200EUR$4,750USD£3,626GBP
- Report
- January 2024
- 103 Pages
Global
From €3500EUR$4,241USD£3,127GBP
- Report
- August 2025
- 50 Pages
Global
From €2343EUR$2,650USD£2,023GBP
- Report
- August 2025
- 50 Pages
Global
From €2343EUR$2,650USD£2,023GBP
- Report
- August 2025
- 50 Pages
Global
From €2343EUR$2,650USD£2,023GBP
- Report
- August 2025
- 50 Pages
Global
From €2343EUR$2,650USD£2,023GBP
- Book
- July 2023
- 1568 Pages
Hydroxyzine is a medication used to treat mental disorders, such as anxiety, tension, and agitation. It is a sedative-hypnotic drug, meaning it has a calming effect on the central nervous system. It is also used to treat nausea, vomiting, and itching. Hydroxyzine is available in both oral and injectable forms. It is generally well-tolerated, with few side effects.
Hydroxyzine is used to treat a variety of mental disorders, including anxiety, panic disorder, obsessive-compulsive disorder, post-traumatic stress disorder, and bipolar disorder. It is also used to treat insomnia, as well as nausea and vomiting associated with chemotherapy.
Hydroxyzine is a popular choice for treating mental disorders due to its effectiveness and low risk of side effects. It is available in generic and brand-name forms, and is often prescribed in combination with other medications.
Some companies in the Hydroxyzine market include Pfizer, Mylan, Teva Pharmaceuticals, and Sandoz. Show Less Read more